XTX Topco’s National Health Investors NHI Stock Holding History

XTX Topco’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,926	Closed	-$203K	–	1685
2023 Q1	$203K	Buy	+3,926	New	+$214K	0.04%	954
2021 Q3	–	Sell	-3,582	Closed	-$240K	–	940
2021 Q2	$240K	Buy	+3,582	New	+$250K	0.08%	479

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco's NHI Position: Q2 2023 in Review

XTX Topco sold out of National Health Investors (NHI) in Q2 2023, closing a stake of 3,926 shares — an estimated $203K sold.

XTX Topco first reported a position in NHI in Q2 2021 and held it in 2 quarters. The position peaked at $240K in Q2 2021. 211 funds tracked by Wall St. Rank hold NHI as of Q2 2023.

XTX Topco reported no remaining National Health Investors position as of Q2 2023 after selling out during the quarter.
XTX Topco sold 3,926 National Health Investors shares in Q2 2023, an estimated $203K.
XTX Topco first reported a position in National Health Investors in Q2 2021 and held it in 2 quarters.
XTX Topco's National Health Investors position peaked at $240K in Q2 2021.
211 funds tracked by Wall St. Rank held National Health Investors as of Q2 2023.

Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.